Eagle’s Eye View: What is the role of inflammation as a predictor of coronary risk?

In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.

Twitter Links:

Clinical Topics: Arrhythmias and Clinical EP, Dyslipidemia, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Nonstatins

Keywords: EaglesEyeView, Atrial Fibrillation, Lung Diseases, Interstitial, Lung Neoplasms, Cholesterol, LDL, C-Reactive Protein, Inflammation, Antihypertensive Agents, Blood Pressure, Denervation


< Back to Listings